Donor Hepatectomy and Implantation Time Are Associated With Early Complications After Liver Transplantation: A Single-center Retrospective Study.


Journal

Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144

Informations de publication

Date de publication:
01 05 2021
Historique:
pubmed: 15 10 2020
medline: 27 7 2021
entrez: 14 10 2020
Statut: ppublish

Résumé

Donor hepatectomy and liver implantation time reduce long-term graft and patient survival after liver transplantation. It is not known whether these surgical times influence early outcomes after liver transplantation. This single-center study evaluated the effect of donor hepatectomy and implantation time on the risk of nonanastomotic biliary strictures (NAS) occurring within 1 year and of early allograft dysfunction (EAD) after deceased-donor solitary liver transplantation, adjusting for other donors, recipient, and surgical factors. Of 917 transplants performed between January 2000 and December 2016, 106 (11.56%) developed NAS and 247 (27%) developed EAD. Donor hepatectomy time (median 35 min, IQR: 26-46) was an independent risk factor of NAS [adjusted hazard ratio, 1.19; 95% CI, 1.04-1.35; P = 0.01]. Implantation time (median 80 min, IQR: 69-95) was independently associated with EAD [adjusted odds ratio (OR), 1.15; 95% CI,1.07-1.23; P < 0.0001). The risk of EAD was increased by anastomosis time of both portal vein (adjusted OR, 1.26; 95% CI, 1.12-14.42; P = 0.0001) and hepatic artery (adjusted OR, 1.13; 95% CI, 1.04-1.22; P = 0.005). The magnitude of these effects was similar in donation after circulatory death liver grafts. Donor hepatectomy and implantation time negatively affect short-term outcomes.

Sections du résumé

BACKGROUND
Donor hepatectomy and liver implantation time reduce long-term graft and patient survival after liver transplantation. It is not known whether these surgical times influence early outcomes after liver transplantation.
METHODS
This single-center study evaluated the effect of donor hepatectomy and implantation time on the risk of nonanastomotic biliary strictures (NAS) occurring within 1 year and of early allograft dysfunction (EAD) after deceased-donor solitary liver transplantation, adjusting for other donors, recipient, and surgical factors.
RESULTS
Of 917 transplants performed between January 2000 and December 2016, 106 (11.56%) developed NAS and 247 (27%) developed EAD. Donor hepatectomy time (median 35 min, IQR: 26-46) was an independent risk factor of NAS [adjusted hazard ratio, 1.19; 95% CI, 1.04-1.35; P = 0.01]. Implantation time (median 80 min, IQR: 69-95) was independently associated with EAD [adjusted odds ratio (OR), 1.15; 95% CI,1.07-1.23; P < 0.0001). The risk of EAD was increased by anastomosis time of both portal vein (adjusted OR, 1.26; 95% CI, 1.12-14.42; P = 0.0001) and hepatic artery (adjusted OR, 1.13; 95% CI, 1.04-1.22; P = 0.005). The magnitude of these effects was similar in donation after circulatory death liver grafts.
CONCLUSIONS
Donor hepatectomy and implantation time negatively affect short-term outcomes.

Identifiants

pubmed: 33052640
pii: 00007890-202105000-00017
doi: 10.1097/TP.0000000000003335
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1030-1038

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no funding or conflicts of interest.

Références

Jochmans I, Fieuws S, Tieken I, et al. The impact of hepatectomy time of the liver graft on post-transplant outcome: a Eurotransplant cohort study. Ann Surg. 2019;269:712–717.
Jochmans I, Fieuws S, Tieken I, et al. The impact of implantation time during liver transplantation on outcome: a Eurotransplant cohort study. Transplant Direct. 2018;4:e356.
Farid SG, Attia MS, Vijayanand D, et al. Impact of donor hepatectomy time during organ procurement in donation after circulatory death liver transplantation: the United Kingdom experience. Transplantation. 2019;103:e79–e88.
Buchholz BM, Gerlach UA, Chandrabalan VV, et al. Revascularization time in liver transplantation: independent prediction of inferior short- and long-term outcomes by prolonged graft implantation. Transplantation. 2018;102:2038–2055.
de Vries Y, von Meijenfeldt FA, Porte RJ. Post-transplant cholangiopathy: classification, pathogenesis, and preventive strategies. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1507–1515.
Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16:943–949.
Adelmann D, Roll GR, Kothari R, et al. The impact of deceased donor liver extraction time on early allograft function in adult liver transplant recipients. Transplantation. 2018;102:e466–e471.
Jochmans I, Van Rosmalen M, Pirenne J, et al. Adult liver allocation in Eurotransplant. Transplantation. 2017;101:1542–1550.
Braat AE, Blok JJ, Putter H, et al. The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant. 2012;12:2789–2796.
Starzl TE, Hakala TR, Shaw BW, et al. A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet. 1984;158:223–230. https://pubmed.ncbi.nlm.nih.gov/6367113/ . Accessed January 8, 2018.
Wolthuis AM, Monbaliu D, Coosemans W, et al. MacPhee AM, Froněk J, eds. Deceased Donor Retrieval. In: Handbook of Renal and Pancreatic Transplantation. 2012. Hoboken, NJ: John Wiley & Sons Ltd91–107.
Thuong M, Ruiz A, Evrard P, et al. New classification of donation after circulatory death donors definitions and terminology. Transpl Int. 2016;29:749–759.
Gilbo N, Jochmans I, Jacobs-Tulleneers-Thevissen D, et al. Survival of patients with liver transplants donated after euthanasia, circulatory death, or brain death at a single center in Belgium. JAMA. 2019;322:78–80.
Noack K, Bronk SF, Kato A, et al. The greater vulnerability of bile duct cells to reoxygenation injury than to anoxia. Implications for the pathogenesis of biliary strictures after liver transplantation. Transplantation. 1993;56:495–500. http://www.ncbi.nlm.nih.gov/pubmed/8212138 . Accessed January 30, 2018.
Rauen U, Kerkweg U, de Groot H. Iron-dependent vs. iron-independent cold-induced injury to cultured rat hepatocytes: a comparative study in physiological media and organ preservation solutions. Cryobiology. 2007;54:77–86.
Martin JL, Costa ASH, Gruszczyk AV, et al. Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation. Nat Metab. 2019;1:966–974.
de Graauw JA, Mihály S, Deme O, et al. Exchange of best practices within the European Union: surgery standardization of abdominal organ retrieval. Transplant Proc. 2014;46:2070–2074.
Brustia R, Boleslawski E, Danion J, et al. The impact of deceased donor liver extraction time on early allograft function in adult liver transplant recipients. “Vite fait, bien fait.” Transplantation. 2019;103:e218–e219.
Blok JJ, de Boer JD, Putter H, et al. The center effect in liver transplantation in the Eurotransplant region: a retrospective database analysis. Transpl Int. 2018;31:610–619.
Van Raemdonck DE, Jannis NC, De Leyn PR, et al. Warm ischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg. 1998;228:788–796. http://www.ncbi.nlm.nih.gov/pubmed/9860478 . Accessed February 16, 2018.
Pierre L, Lindstedt S, Ingemansson R. Ventilation in situ after cardiac death improves pulmonary grafts exposed to 2 hours of warm ischemia. Scand Cardiovasc J. 2015;49:293–298.

Auteurs

Nicholas Gilbo (N)

Lab of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Abdominal Transplantation Surgery and Coordination, University Hospitals Leuven, Leuven, Belgium.

Steffen Fieuws (S)

Department of Public Health, Interuniversity Centre for Biostatistics and Statistical Bioinformatics, KU Leuven, Leuven, Belgium.

Nicolas Meurisse (N)

Department of Abdominal Transplant Surgery, University of Liege Academic Hospital, Liège, Belgium.

Frederik Nevens (F)

Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.

Schalk van der Merwe (S)

Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.

Wim Laleman (W)

Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.

Chris Verslype (C)

Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.

David Cassiman (D)

Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.

Hannah van Malenstein (H)

Department of Gastroenterology and Hepatology, KU Leuven, Leuven, Belgium.

Tania Roskams (T)

Department of Imaging and Pathology, Translational Cell and Tissue Research, KU Leuven, Leuven, Belgium.

Mauricio Sainz-Barriga (M)

Lab of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Abdominal Transplantation Surgery and Coordination, University Hospitals Leuven, Leuven, Belgium.

Jacques Pirenne (J)

Lab of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Abdominal Transplantation Surgery and Coordination, University Hospitals Leuven, Leuven, Belgium.

Ina Jochmans (I)

Lab of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Abdominal Transplantation Surgery and Coordination, University Hospitals Leuven, Leuven, Belgium.

Diethard Monbaliu (D)

Lab of Abdominal Transplantation, Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Abdominal Transplantation Surgery and Coordination, University Hospitals Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH